GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM33604
Query DataSets for GSM33604
Status
Public on Oct 30, 2004
Title
nck2 hybB
Sample type
RNA
Source name
danio rerio nck2 morpholino
Organism
Danio rerio
Extracted molecule
total RNA
Description
total RNA derived from danio rerio nck2 morpholino
Submission date
Oct 27, 2004
Last update date
May 27, 2005
Contact name
Henning Witt
E-mail(s)
witt@molgen.mpg.de
Phone
++49-30-450578727
Organization name
Max Planck Institute for Molecular Genetics
Department
Hans Lehrach
Lab
Patricia Ruiz
Street address
Ihnestrasse 65
City
Berlin
ZIP/Postal code
14195
Country
Germany
Platform ID
GPL1319
Series (1)
GSE1894
nck2 vs. wt morpholino
Data table header descriptions
ID_REF
VALUE
normalized intenssity
SIGNAL_RAW
raw intensity
DETECTION P-VALUE
detection p-value
Data table
ID_REF
VALUE
SIGNAL_RAW
DETECTION P-VALUE
AFFX-BioB-3_at
847.3
33.9
0.020022
AFFX-BioB-5_at
1589.6
63.6
0.004998
AFFX-BioB-M_at
1692.1
67.7
0.000081
AFFX-BioC-3_at
2464.4
98.6
0.000052
AFFX-BioC-5_at
3716.6
148.7
0.000195
AFFX-BioDn-3_at
17738
709.7
0.00007
AFFX-BioDn-5_at
3304.2
132.2
0.000044
AFFX-CreX-3_at
72516.6
2901.4
0.000052
AFFX-CreX-5_at
37780.4
1511.6
0.000044
AFFX-DapX-3_at
47.5
1.9
0.916408
AFFX-DapX-5_at
282.4
11.3
0.185131
AFFX-DapX-M_at
252.4
10.1
0.340661
AFFX-Dr-AB076373-1_at
102.5
4.1
0.67917
AFFX-Dr-acta1-3_at
231146.5
9248.2
0.000219
AFFX-Dr-acta1-5_at
55193.5
2208.3
0.000977
AFFX-Dr-acta1-5_x_at
110829.4
4434.3
0.000219
AFFX-Dr-acta1-M_at
190186.8
7609.4
0.000219
AFFX-Dr-AF292559-1_at
177.5
7.1
0.35869
AFFX-Dr-AF292559-2_s_at
97.5
3.9
0.47938
AFFX-Dr-AF292559-3_s_at
177.5
7.1
0.458816
Total number of rows:
15617
Table truncated, full table size
561 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|